Skip to main content

Want a detailed portfolio tracker?

Autolus Therapeutics (AUTL) P/E (2022 - 2026)

Autolus Therapeutics (AUTL) P/E from Sep 30, 2022 to Jun 3, 2026. The TTM Autolus Therapeutics (AUTL) P/E is -1.60. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Autolus Therapeutics (AUTL)

YearP/EChange
2026-1.60-15.41%
2025-1.90-17.03%
2024-2.29-56.55%
2023-5.26+30.07%
2022-4.04N/A

Comparison Autolus Therapeutics (AUTL) P/E with competitors

Autolus Therapeutics (AUTL) P/E is -1.60.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.11%
NBYStablecoin Development Corp0.10-106.37%
ENLVEnlivex Therapeutics Ltd0.15-109.36%
FGENFibroGen Inc0.24-114.97%
TRAWTraws Pharma Inc0.47-129.48%
FBIOFortress Biotech Inc0.71-144.02%
CHRSCoherus Biosciences Inc0.98-160.98%
ORMPOramed Pharmaceuticals Inc1.47-191.86%
AGENAgenus Inc2.05-227.71%
VIVSVivoSim Labs Inc2.54-258.09%
INVAInnoviva Inc3.19-298.78%
CRMDCorMedix Inc3.65-327.29%
ABEOAbeona Therapeutics Inc4.20-362.16%
VXRTVaxart Inc4.26-365.69%
CVACCureVac N.V.4.45-377.16%
SRPTSarepta Therapeutics Inc4.62-388.29%
GLPGGalapagos NV4.86-402.92%
RIGLRigel Pharmaceuticals4.92-406.70%
ZVRAZevra Therapeutics Inc4.97-410.10%
ABUSArbutus Biopharma Corp5.69-454.97%
CGENCompugen Ltd7.38-560.35%
AUPHAurinia Pharmaceuticals Inc9.25-676.78%
ACADAcadia Pharmaceuticals Inc9.59-697.77%
OMEROmeros Corporation9.88-716.18%
PLXProtalix BioTherapeutics Inc9.91-717.78%
SPROSpero Therapeutics Inc10.73-769.26%
ADMAAdma Biologics Inc11.33-806.41%
SVASinovac Biotech Ltd11.44-812.98%
TBPHTheravance Biopharma Inc11.78-834.22%
HRMYHarmony Biosciences Holdings Inc12.18-859.39%
TGTXTG Therapeutics Inc13.18-921.67%
INCYIncyte Corp13.38-934.31%
SABSSAB Biotherapeutics Inc14.06-976.43%
XOMAXOMA Corp14.95-1031.76%
REGNRegeneron Pharmaceuticals Inc14.98-1033.95%
PBYIPuma Biotechnology Inc15.05-1038.32%
EXELExelixis Inc15.79-1084.73%
NAGENiagen Bioscience Inc16.35-1119.65%
CPRXCatalyst Pharmaceuticals Inc17.34-1181.36%
MDXGMimedx Group Inc17.38-1183.27%
ARGXArgen X SE23.07-1538.41%
HALOHalozyme Therapeutics Inc23.20-1546.45%
XOMAOXOMA Corp25.34-1680.13%
VRTXVertex Pharmaceuticals Inc25.66-1699.52%
XOMAPXOMA Corp25.67-1700.41%
CTMXCytomX Therapeutics Inc25.70-1702.14%
ASNDAscendis Pharma A/S26.35-1743.06%
RPRXRoyalty Pharma plc - Class A27.50-1814.21%
SLNOSoleno Therapeutics Inc29.02-1908.97%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1981.99%
BMRNBiomarin Pharmaceutical Inc37.51-2438.40%
APLSApellis Pharmaceuticals Inc39.02-2532.79%
KRYSKrystal Biotech Inc39.70-2574.96%
GMABGenmab40.20-2606.51%
ONCBeiGene Ltd67.03-4278.82%
TECHBio-Techne Corp68.59-4376.59%
VCELVericel Corp80.63-5126.86%
PHARPharming Group N.V.87.74-5570.20%
ALNYAlnylam Pharmaceuticals Inc124.93-7889.04%
TLXTelix Pharmaceuticals Ltd139.89-8821.54%
CORTCorcept Therapeutics Inc158.39-9974.85%